NYSE:PFE - New York Stock Exchange, Inc. - US7170811035 - Common Stock - Currency: USD
Overall PFE gets a fundamental rating of 6 out of 10. We evaluated PFE against 198 industry peers in the Pharmaceuticals industry. PFE scores excellent on profitability, but there are some minor concerns on its financial health. PFE scores decently on growth, while it is valued quite cheap. This could make an interesting combination. Finally PFE also has an excellent dividend rating.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.79% | ||
ROE | 8.73% | ||
ROIC | 7.77% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 27.12% | ||
PM (TTM) | 12.62% | ||
GM | 74.57% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.65 | ||
Debt/FCF | 5.54 | ||
Altman-Z | 2.09 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.26 | ||
Quick Ratio | 0.96 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 6.86 | ||
Fwd PE | 7.19 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 11.13 | ||
EV/EBITDA | 6.62 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 7.49% |
22.02
-0.85 (-3.72%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 7.49% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 6.86 | ||
Fwd PE | 7.19 | ||
P/S | 2 | ||
P/FCF | 11.13 | ||
P/OCF | 8.93 | ||
P/B | 1.38 | ||
P/tB | N/A | ||
EV/EBITDA | 6.62 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.79% | ||
ROE | 8.73% | ||
ROCE | 9.87% | ||
ROIC | 7.77% | ||
ROICexc | 8.64% | ||
ROICexgc | 41.11% | ||
OM | 27.12% | ||
PM (TTM) | 12.62% | ||
GM | 74.57% | ||
FCFM | 17.96% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.65 | ||
Debt/FCF | 5.54 | ||
Debt/EBITDA | 2.45 | ||
Cap/Depr | 40.16% | ||
Cap/Sales | 4.43% | ||
Interest Coverage | 5.35 | ||
Cash Conversion | 58.69% | ||
Profit Quality | 142.33% | ||
Current Ratio | 1.26 | ||
Quick Ratio | 0.96 | ||
Altman-Z | 2.09 |